Community acquired viral hepatitis B and C in the United States.
Open Access
- 1 January 1993
- Vol. 34 (2 Suppl) , S17-S19
- https://doi.org/10.1136/gut.34.2_suppl.s17
Abstract
In the United States, most reported cases of hepatitis B occur in adults as a result of behavioural, lifestyle, or occupational exposures, but a significant number of children also become infected in well defined settings. Although only 1-3% of acute hepatitis B virus (HBV) infections occur in children under 5 years of age, they account for 20-30% of all chronic infections. A new strategy for HBV prevention in the USA includes integration of HBV vaccine into childhood immunisation schedules. Vaccination strategies that target high risk groups have not been effective. To determine the frequency and severity of community acquired chronic hepatitis C, patients with acute non-A, non-B hepatitis identified in four sentinel counties in the United States were followed prospectively. Hepatitis C virus (HCV) infection was found in 106 (82%) of 130 patients. Ninety three per cent of the HCV positive patients had a risk factor for their infection: 59% parenteral, 6% sexual or household, and 28% low socioeconomic level. Chronic hepatitis developed in 62%, independently of the risk factor for infection. HCV-RNA persisted in most patients, including those with biochemical resolution of their hepatitis. This study suggests that HCV may be a major cause of liver disease and persistent viraemia in the United States.Keywords
This publication has 7 references indexed in Scilit:
- The Natural History of Community-Acquired Hepatitis C in the United StatesNew England Journal of Medicine, 1992
- Hepatitis C virus antigen in hepatocytes: Immunomorphologic detection and identificationGastroenterology, 1992
- Temporal relationships of hepatitis C virus RNA and antibody responses following experimental infection of chimpanzeesJournal of Medical Virology, 1992
- Hepatitis C Virus Infection in Post-Transfusion HepatitisNew England Journal of Medicine, 1991
- Hepatitis B: Evolving Epidemiology and Implications for ControlSeminars in Liver Disease, 1991
- Specificity of anti-HCV ELISA assessed by reactivity to three immunodominant HCV regionsThe Lancet, 1990
- Sporadic Non-A, Non-B Hepatitis: Frequency and Epidemiology in an Urban U.S. PopulationThe Journal of Infectious Diseases, 1982